Evaluating the effect of Edaravone on clinical outcome of patients with severe COVID-19 admitted to ICU: a randomized clinical trial.
Moslemi M, Hejazian SM, Shaddelan M, Javanali F, Mirghaffari A, Sadeghi A, Valizadeh H, Sharifi A, Haramshahi M, Ardalan M, Zununi Vahed S.
Moslemi M, et al.
Inflammopharmacology. 2022 Aug;30(4):1277-1282. doi: 10.1007/s10787-022-01001-2. Epub 2022 Jun 20.
Inflammopharmacology. 2022.
PMID: 35723849
Free PMC article.
Clinical Trial.
Edaravone administration improved the primary outcomes; it decreased the need for endotracheal intubation and mechanical ventilation [10.52% (n = 2) versus 42.1% (n = 8); p = 0.03] and intubation length [3 (1-7) versus 28 (4-28), p = 0.04] compared to control group. …
Edaravone administration improved the primary outcomes; it decreased the need for endotracheal intubation and mechanical ventilation [10.52% …